SAN DIEGO — New data confirmed the safety and efficacy of AXS-05, a combination of dextromethorphan and bupropion, for the treatment of agitation associated with Alzheimer’s disease (AD).

A cough that lingers after a cold or the flu is usually not something to worry about. Known as a post-infectious or post-viral cough, this lingering cough affects 11% to 25% of adults who have ...

3,8 As dextromethorphan is a substrate for CYP2D6 and quinidine is an inhibitor of CYP2D6 and p-glycoprotein, there is the potential for drug interactions. 44 Dose reductions of desipramine ...